Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jingwen Qu, Jiahong Lu & Yuanjia Hu. (2019) Research and development of anti-Parkinson’s drugs: an analysis from the perspective of technology flows measured by patent citations. Expert Opinion on Therapeutic Patents 29:2, pages 127-135.
Read now
Read now
Articles from other publishers (23)
Prashant Sharma, Abhinoy Kishore, Indranil De, Swarnima Negi, Gulshan Kumar, Sahil Bhardwaj & Manish Singh. (2023) Mitigating neuroinflammation in Parkinson's disease: Exploring the role of proinflammatory cytokines and the potential of phytochemicals as natural therapeutics. Neurochemistry International, pages 105604.
Crossref
Crossref
Fahim Muhammad, Yan Liu, Ningbo Wang, Longhe Zhao, Yangtao Zhou, Hui Yang & Hongyu Li. (2023)
Rose essential oil diminishes dopaminergic neuron degenerations and reduces α‐synuclein aggregation in
Caenorhabditis elegans
models of Parkinson's disease
. Phytotherapy Research 37:7, pages 2877-2893.
Crossref
Crossref
Yongjun Wang, Zhengjia Pu, Yiran Zhang, Zhaohui Du, Zeming Guo & Qunhua Bai. (2023) Exercise training has a protective effect in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model with improved neural and intestinal pathology and modified intestinal flora. Behavioural Brain Research 439, pages 114240.
Crossref
Crossref
Carolin Thomas, Lia Wurzer, Ernst Malle, Michael Ristow & Corina T. Madreiter-Sokolowski. (2022) Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs. Frontiers in Aging 3.
Crossref
Crossref
Ye Zhang, Ruixin Wang, Chunyan He, Yu-Fang Zhang, Zhongrui Luo, Jia Luo, Sisi Chen, Yu Jin, Bowen Xie & Ye Liu. (2022) Amantadine-assembled nanostimulator enhances dimeric RBD antigen-elicited cross-neutralization against SARS-CoV-2 strains. Nano Today 43, pages 101393.
Crossref
Crossref
Prakash Navaratnam, Steve Arcona, Howard S. Friedman, Matthew Leoni, Shajahan Shaik & Rahul Sasane. (2022) Natural history and patterns of treatment change in Parkinson’s disease: A retrospective chart review. Clinical Parkinsonism & Related Disorders 6, pages 100125.
Crossref
Crossref
Shirel Argueti-Ostrovsky, Leenor Alfahel, Joy Kahn & Adrian Israelson. (2021) All Roads Lead to Rome: Different Molecular Players Converge to Common Toxic Pathways in Neurodegeneration. Cells 10:9, pages 2438.
Crossref
Crossref
Bhumika Kumar, Mukesh Pandey, Faheem H. Pottoo, Faizana Fayaz, Anjali Sharma & P.K. Sahoo. (2020) Liposomes: Novel Drug Delivery Approach for Targeting Parkinson’s Disease. Current Pharmaceutical Design 26:37, pages 4721-4737.
Crossref
Crossref
Martin Klietz, Stephan Greten, Florian Wegner & Günter U. Höglinger. (2019) Safety and Tolerability of Pharmacotherapies for Parkinson’s Disease in Geriatric Patients. Drugs & Aging 36:6, pages 511-530.
Crossref
Crossref
Hwei-Hsien Chen, Pei-Chi Chang, Shiaw-Pyng Wey, Pei-Mei Chen, Chinpiao Chen & Ming-Huan Chan. (2018) Therapeutic effects of honokiol on motor impairment in hemiparkinsonian mice are associated with reversing neurodegeneration and targeting PPARγ regulation. Biomedicine & Pharmacotherapy 108, pages 254-262.
Crossref
Crossref
Weiyu Li, Yekkuni L. Balachandran, Yanling Hao, Xie Hao, Runzhi Li, Zhangjie Nan, Hongying Zhang, Yiming Shao & Ye Liu. (2018) Amantadine Surface-Modified Silver Nanorods Improves Immunotherapy of HIV Vaccine Against HIV-Infected Cells. ACS Applied Materials & Interfaces 10:34, pages 28494-28501.
Crossref
Crossref
Hwei-Hsien Chen, Pei-Chi Chang, Chinpiao Chen & Ming-Huan Chan. (2018) Protective and therapeutic activity of honokiol in reversing motor deficits and neuronal degeneration in the mouse model of Parkinson’s disease. Pharmacological Reports 70:4, pages 668-676.
Crossref
Crossref
Santiago Perez-Lloret & Olivier Rascol. (2018) Efficacy and safety of amantadine for the treatment of l-DOPA-induced dyskinesia. Journal of Neural Transmission 125:8, pages 1237-1250.
Crossref
Crossref
Qiang Li, Chengu Niu, Xiaojie Zhang & Miaoxian Dong. (2017)
Gastrodin and Isorhynchophylline Synergistically Inhibit MPP
+
-Induced Oxidative Stress in SH-SY5Y Cells by Targeting ERK1/2 and GSK-3β Pathways: Involvement of Nrf2 Nuclear Translocation
. ACS Chemical Neuroscience 9:3, pages 482-493.
Crossref
Crossref
Wolfgang H. Jost & Jennifer Bausch. (2017) Patients’ perspective on current treatment options for Parkinson’s Disease. Basal Ganglia 9, pages 7-11.
Crossref
Crossref
Pornpan Prapatpong, Brompoj Prutthiwanasan, Nantana Nuchtavorn, Sawanya Buranaphalin & Leena Suntornsuk. (2017) Brompheniramine as a novel probe for indirect UV detection and its application for the capillary electrophoresis of adamantane drugs. Journal of Separation Science 40:5, pages 1184-1192.
Crossref
Crossref
Chi Zhang, Xianrui Yuan, Zhongliang Hu, Songlin Liu, Haoyu Li, Ming Wu, Jian Yuan, Zijin Zhao, Jun Su, Xiangyu Wang, Yiwei Liao & Qing Liu. (2017)
Valproic Acid Protects Primary Dopamine Neurons from MPP
+
-Induced Neurotoxicity: Involvement of GSK3
β
Phosphorylation by Akt and ERK through the Mitochondrial Intrinsic Apoptotic Pathway
. BioMed Research International 2017, pages 1-12.
Crossref
Crossref
Nuno Pereira, Francesc Sureda, Maria Pérez, Mercedes Amat & Maria Santos. (2016) Enantiopure Indolo[2,3-a]quinolizidines: Synthesis and Evaluation as NMDA Receptor Antagonists. Molecules 21:8, pages 1027.
Crossref
Crossref
Vishruti Makani, Yong-gil Jang, Kevin Christopher, Wesley Judy, Jacob Eckstein, Kenneth Hensley, Nicolas Chiaia, Dong-Shik Kim & Joshua Park. (2016) BBB-Permeable, Neuroprotective, and Neurotrophic Polysaccharide, Midi-GAGR. PLOS ONE 11:3, pages e0149715.
Crossref
Crossref
Maria I. VenturaJerri D. EdwardsDeborah E. Barnes. (2015) More than just a movement disorder. Neurology 85:21, pages 1828-1829.
Crossref
Crossref
Thomas J. Montine & Kathleen S. Montine. (2015) Precision medicine: Clarity for the clinical and biological complexity of Alzheimer’s and Parkinson’s diseases. Journal of Experimental Medicine 212:5, pages 601-605.
Crossref
Crossref
Toshio Nakaki. 2015. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions
163
174
.
Etheresia Pretorius, Albe C Swanepoel, Antoinette V Buys, Natasha Vermeulen, Wiebren Duim & Douglas B Kell. (2014) Eryptosis as a marker of Parkinson's disease. Aging 6:10, pages 788-819.
Crossref
Crossref